Summary
Belgian chemicals group UCB said yesterday it is to buy UK biotechnology firm Celltech for pounds 1.5bn.
Brussels-based UCB said Celltech's directors had given a thumbs- up to its bid, under which the UK group's investors would receive 550p per ordinary share.See the full content of this document
Extract
Belgians to Buy Celltech
It said the merger would create one of the world's biggest biopharmaceuti...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Costelow Engineering Services Limited | Roman Helmet Puzzle | trim named cleanest of irish towns ; award | Film Their Eyes Were Watching [...] | 19 CFR 24.11 - Notice to importer or owner of increased or additional duties, taxes, fees and interest. | 20 CFR 219.5 Where and how to provide evidence. | 40 CFR 407.56 Pretreatment standards for new sources. | United States v. Edwards, 415 U.S. 800 (1974)
